News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68 Results
Type
Article (2)
Press Release (66)
Section
Business (13)
Deals (4)
Drug Development (1)
News (18)
Tag
Earnings (6)
Events (13)
FDA (1)
GLP-1 (4)
Healthcare (5)
IPO (5)
Medical device (4)
Medtech (4)
Mergers & acquisitions (1)
Metabolic disorders (4)
Obesity (3)
Patents (1)
People (9)
Pipeline (1)
United States (17)
Weight loss (1)
Date
Last 30 days (2)
Last 365 days (22)
2025 (9)
2024 (19)
2023 (9)
2022 (3)
2021 (10)
2020 (5)
2019 (1)
2018 (4)
2017 (3)
2016 (1)
2015 (1)
2014 (1)
2012 (1)
2011 (1)
Location
Delaware (1)
Europe (1)
Massachusetts (15)
Texas (1)
68 Results for "allurion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity
February 18, 2025
·
5 min read
Press Releases
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
March 20, 2025
·
6 min read
Press Releases
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
January 23, 2025
·
5 min read
Press Releases
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 27, 2025
·
12 min read
Press Releases
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
February 20, 2025
·
6 min read
Press Releases
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
March 5, 2025
·
5 min read
Press Releases
Allurion Announces Positive Topline Results From AUDACITY Trial
January 8, 2025
·
7 min read
Press Releases
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
February 19, 2025
·
6 min read
Press Releases
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
January 24, 2025
·
6 min read
Business
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
Allurion Technologies, Inc. today announced the appointment of Ojas A. Buch as its new Chief Operating Officer.
June 5, 2024
·
5 min read
1 of 7
Next